Ginkgoselect Phytosome
This article was originally published in The Tan Sheet
Executive Summary
Ginkgo extract complex with soy phospholipids demonstrates superior bioavailability and improved antioxidant action relative to a standard extract, Indena researchers report at a symposium during the American Society of Pharmacognosy annual meeting in Seattle July 23. The Italian firm maintains the complex is well-tolerated in rats and does not interfere with primary haemostasis at pharmacologically active doses. The compound is a good candidate for future, long-term clinical trials at reduced doses, Indena suggests. The company specializes in the extraction of plant-based active substances for the pharmaceutical, cosmetic and dietary supplement industries
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning